Superworth

Cadre EPS CDRE

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Last 12 months, to Jun 30, 2026
$0.81
Latest quarter, Q2 FY26
$0.26
−13% on a year earlier
Fiscal year 2025
$1.03
+14% on the year before

Cadre's earnings per share was $0.81 over the twelve months to Jun 30, 2026, down 14% on a year earlier.

In its latest quarter, Q2 FY26, it was $0.26, down 13% on the same quarter a year before.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025$1.03+14%
FY2024$0.90−12%
FY2023$1.02+685%
FY2022$0.13−70%
FY2021$0.44n/a
FY2020n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26$0.26−13%$0.81
Q1 FY26$0.05−78%$0.85
Q4 FY25$0.23−28%$1.03
Q3 FY25$0.27+200%$1.12
Q2 FY25$0.30−3%$0.94
Q1 FY25$0.23+28%$0.95
Q4 FY24$0.32+28%$0.90
Q3 FY24$0.09−69%$0.83
Q2 FY24$0.31+7%$1.03
Q1 FY24$0.18−5%$1.01
Q4 FY23$0.25+39%$1.02
Q3 FY23$0.29+123%$0.95

Against its peers

Companies in Medical - Instruments & Supplies nearest Cadre's size, closest first, today.

CompanyEPS, 12 monthsGrowth
CDRECadre$0.81−14% a year
BVSBioventus$0.77
STAAStaar Surgical$0.07
EYENational Vision$0.61
IRMDIradimed$1.79+10% a year
LMATLemaitre Vascular$2.85+38% a year
INSPInspire Medical Systems$4.62+166% a year
UFPTUFP Technologies$9.28+8% a year
MOVMovado$1.80+137% a year
MDXGMimedx$0.04−81% a year
ATRCAtriCure$0.21
Peer median$1.28

Where Cadre ranks

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Cadre

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.